FDA Finalizes Peripheral Vascular Atherectomy Guidance
Executive Summary
The US agency made few changes in finalizing a 13 February guidance document on medical devices made to remove plaque from diseased arteries, but did incorporate manufacturer recommendations on corrosion testing and predicate comparisons.
You may also be interested in...
FDA Proposes Updates To Peripheral Vascular Atherectomy Devices Guidance
US regulators are proposing updates to a guidance document they finalized in February for devices used to clear arteries of plaque. The updated language specifically addresses software interoperability, pyrogenicity and certain performance-testing requirements.
Final Q-Sub Guidance Describes FDA Meeting Policy
A new final guidance document from the US FDA explains how the agency wants device developers to use its Q-Submission Program to get agency feedback outside the formal product submission process.
Clinical Trials Sought For Atherectomy Device 510(k)s In FDA Guidance
New US FDA draft guidance on 510(k)s for peripheral vascular atherectomy devices asks sponsors to submit clinical trial data due to lack of a good animal model.
Need a specific report? 1000+ reports available Buy Reports
Register for our free email digests: